128 related articles for article (PubMed ID: 10616359)
1. Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy.
Ball JK; Rowe T; Curran R; Irving WL; Beards GM; Sontag G; Youle M; Moyle G; Pillay D
Sex Transm Infect; 1999 Oct; 75(5):337-9. PubMed ID: 10616359
[TBL] [Abstract][Full Text] [Related]
2. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.
Lafeuillade A; Solas C; Halfon P; Chadapaud S; Hittinger G; Lacarelle B
HIV Clin Trials; 2002; 3(1):27-35. PubMed ID: 11819183
[TBL] [Abstract][Full Text] [Related]
3. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy.
Craigo JK; Patterson BK; Paranjpe S; Kulka K; Ding M; Mellors J; Montelaro RC; Gupta P
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1196-209. PubMed ID: 15588342
[TBL] [Abstract][Full Text] [Related]
4. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.
Gupta P; Mellors J; Kingsley L; Riddler S; Singh MK; Schreiber S; Cronin M; Rinaldo CR
J Virol; 1997 Aug; 71(8):6271-5. PubMed ID: 9223532
[TBL] [Abstract][Full Text] [Related]
5. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
[TBL] [Abstract][Full Text] [Related]
6. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.
Mayer KH; Boswell S; Goldstein R; Lo W; Xu C; Tucker L; DePasquale MP; D'Aquila R; Anderson DJ
Clin Infect Dis; 1999 Jun; 28(6):1252-9. PubMed ID: 10451162
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinations.
Grodesky M; Acosta EP; Fujita N; Mason S; Gerber JG
HIV Clin Trials; 2001; 2(3):193-9. PubMed ID: 11590527
[TBL] [Abstract][Full Text] [Related]
8. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.
Lambert-Niclot S; Tubiana R; Beaudoux C; Lefebvre G; Caby F; Bonmarchand M; Naouri M; Schubert B; Dommergues M; Calvez V; Flandre P; Poirot C; Marcelin AG
AIDS; 2012 May; 26(8):971-5. PubMed ID: 22382146
[TBL] [Abstract][Full Text] [Related]
9. Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system.
Martin C; Sönnerborg A; Svensson JO; Ståhle L
AIDS; 1999 Jul; 13(10):1227-32. PubMed ID: 10416527
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
[TBL] [Abstract][Full Text] [Related]
11. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD
N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141
[TBL] [Abstract][Full Text] [Related]
12. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture.
Dyer JR; Gilliam BL; Eron JJ; Grosso L; Cohen MS; Fiscus SA
J Virol Methods; 1996 Jul; 60(2):161-70. PubMed ID: 8844622
[TBL] [Abstract][Full Text] [Related]
14. Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs.
Chan DJ; Ray JE; McNally L; Batterham M; Smith DE
Curr HIV Res; 2008 Sep; 6(5):477-84. PubMed ID: 18855660
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal comparison between plasma and seminal HIV-1 viral loads during antiretroviral treatment.
Pinto Neto LF; Vieira NF; Soprani M; Cunha CB; Cabral VP; Dietze R; Ribeiro-Rodrigues R
Rev Soc Bras Med Trop; 2003; 36(6):689-94. PubMed ID: 15049108
[TBL] [Abstract][Full Text] [Related]
18. Relationship between HIV-RNA load in blood and semen in antiretroviral-naïve and experienced men and effect of asymptomatic sexually transmissible infections.
Chan DJ; McNally L; Batterham M; Smith DE
Curr HIV Res; 2008 Mar; 6(2):138-42. PubMed ID: 18336261
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies.
Ibáñez A; Clotet B; Martínez MA
J Gen Virol; 2000 Jan; 81(Pt 1):85-95. PubMed ID: 10640545
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP
N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
